-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Chlorazol Violet N
Category | Human immunodeficiency Virus (HIV) |
CAS | 2586-60-9 |
Description | Direct Violet 1, an azo dye, is a textile dye. Direct Violet 1 is also the protein-protein interaction (PPI) between the SARS-CoV-2 spike protein and ACE2 inhibitor with IC50s of 1.47-2.63 µM. |
Product Information
Synonyms | Chlorazol Violet N; Diamine violet; Direct Violet 1 |
IUPAC Name | disodium;6-amino-5-[[4-[4-[(2-amino-8-hydroxy-6-sulfonatonaphthalen-1-yl)diazenyl]phenyl]phenyl]diazenyl]-4-hydroxynaphthalene-2-sulfonate |
Molecular Weight | 728.66 |
Molecular Formula | C32H22N6Na2O8S2 |
Canonical SMILES | C1=CC(=CC=C1C2=CC=C(C=C2)N=NC3=C(C=CC4=CC(=CC(=C43)O)S(=O)(=O)[O-])N)N=NC5=C(C=CC6=CC(=CC(=C65)O)S(=O)(=O)[O-])N.[Na+].[Na+] |
InChI | InChI=1S/C32H24N6O8S2.2Na/c33-25-11-5-19-13-23(47(41,42)43)15-27(39)29(19)31(25)37-35-21-7-1-17(2-8-21)18-3-9-22(10-4-18)36-38-32-26(34)12-6-20-14-24(48(44,45)46)16-28(40)30(20)32;;/h1-16,39-40H,33-34H2,(H,41,42,43)(H,44,45,46);;/q;2*+1/p-2 |
InChIKey | VDRKHPFIMDTBNX-UHFFFAOYSA-L |
Purity | 95% |
Density | 1.64g/cm3 |
Solubility | In Vitro: H2O : 62.5 mg/mL(85.77 mM;Need ultrasonic) |
Appearance | Off-white to brown (Solid) |
Storage | 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months -20°C, 1 month (sealed storage, away from moisture) |
Complexity | 1280 |
Exact Mass | 728.07359259 |
Index Of Refraction | 1.771 |
In Vitro | Direct violet 1 inhibits the binding of SARS-CoV-2-S-RBD to human ACE2, inhibits SARS-CoV-S1S2 binding to ACE2, and inhibits TNF-R1 binding to TNF α IC50 values are 1.47 μM, $2.63 μM, and 2.11 μM, respectively. Direct violet 1 inhibits the entry of SARS-CoV-2 pseudovirus into host cells for hACE2 expression in a concentration-dependent manner with an IC50 of 35.8 μM. |
PSA | 273.10000 |
Target | IC50: 1.47 µM (SARS-CoV-2-S-RBD binding to ACE2); 2.63 µM (SARS-CoV-S1S2 binding to ACE2); 2.11 µM (TNF-R1-TNFα binding) |